Clinical Trials

Title   DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Description   This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors. Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread.
IRB Number   1052374-1
Status   Active
Principal Name   Sachin Pai, MD
Contact Name   Kathleen Ollis

Email Newsletters

Connect With Us